Discovering
novel small molecule drug leads depends on the ability to efficiently search chemical diversity.
Not exact matches
In a
novel animal study design that mimicked human clinical trials, researchers at University of California, San Diego School of Medicine report that long - term treatment using a
small molecule drug that reduces activity of the brain's stress circuitry significantly reduces Alzheimer's disease (AD) neuropathology and prevents onset of cognitive impairment in a mouse model of the neurodegenerative condition.
Anderson and Valerie Grum - Tokars, a junior structural biologist on the team, developed a three - dimensional structure of human p38 MAPK, enabling the chemists to design and synthesize
novel drug - like
small molecules that would disable it.
An emerging strategy in early
drug discovery entails using fragments, i.e.
molecules smaller than conventional
drug candidates, as starting points for design of
novel therapeutic compounds.
Reykjavik, ICELAND, January 13, 2005 — deCODE genetics (Nasdaq: DCGN) has submitted an investigational new
drug application (IND) to the U.S. Food and Drug Administration (FDA) for DG041, a novel, first - in - class, orally - administered small molecule for the treatment o
drug application (IND) to the U.S. Food and
Drug Administration (FDA) for DG041, a novel, first - in - class, orally - administered small molecule for the treatment o
Drug Administration (FDA) for DG041, a
novel, first - in - class, orally - administered
small molecule for the treatment of...
Phenotypic screening of
small molecule libraries using iPSC - based models to identify
novel drug candidates and disease mechanisms.
Carmot's vision is to become a leader in
drug discovery by unlocking
novel therapeutic target space not currently accessible to conventional
small molecule technologies.
It discovers and develops
novel,
small -
molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders.
Rigel Pharmaceuticals, Inc is a clinical - stage
drug development company that discovers and develops
novel,
small -
molecule drugs for the treatment of inflammatory / autoimmune diseases, as well as for certain cancers and metabolic diseases.
Senior manager and director of pharmaceutical process chemistry, manufacturing and controls (CMC) specializing in cGMP, quality and regulatory compliance of
novel small and large
molecule therapeutic
drugs including peptides, nucleotides, protein biologics and antibody
drug conjugates (ADCs).
I am interested in Scientist position for designing and developing
novel small molecules, developing new synthetic routes and process optimization, for
drug discovery and development.